Logo image of UFPT

UFP TECHNOLOGIES INC (UFPT) Stock Fundamental Analysis

NASDAQ:UFPT - US9026731029 - Common Stock

225.74 USD
+6.18 (+2.81%)
Last: 8/22/2025, 8:00:02 PM
225.74 USD
0 (0%)
After Hours: 8/22/2025, 8:00:02 PM
Fundamental Rating

6

Overall UFPT gets a fundamental rating of 6 out of 10. We evaluated UFPT against 185 industry peers in the Health Care Equipment & Supplies industry. While UFPT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. UFPT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes UFPT very considerable for growth investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

UFPT had positive earnings in the past year.
In the past year UFPT had a positive cash flow from operations.
Each year in the past 5 years UFPT has been profitable.
UFPT had a positive operating cash flow in each of the past 5 years.
UFPT Yearly Net Income VS EBIT VS OCF VS FCFUFPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

UFPT has a better Return On Assets (10.57%) than 93.05% of its industry peers.
The Return On Equity of UFPT (17.41%) is better than 91.98% of its industry peers.
UFPT's Return On Invested Capital of 14.00% is amongst the best of the industry. UFPT outperforms 94.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for UFPT is above the industry average of 8.44%.
The last Return On Invested Capital (14.00%) for UFPT is above the 3 year average (11.64%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.57%
ROE 17.41%
ROIC 14%
ROA(3y)10.52%
ROA(5y)8.58%
ROE(3y)16.84%
ROE(5y)13.25%
ROIC(3y)11.64%
ROIC(5y)9.67%
UFPT Yearly ROA, ROE, ROICUFPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

UFPT has a Profit Margin of 11.40%. This is amongst the best in the industry. UFPT outperforms 85.56% of its industry peers.
In the last couple of years the Profit Margin of UFPT has grown nicely.
The Operating Margin of UFPT (16.39%) is better than 86.63% of its industry peers.
In the last couple of years the Operating Margin of UFPT has grown nicely.
The Gross Margin of UFPT (28.76%) is worse than 76.47% of its industry peers.
In the last couple of years the Gross Margin of UFPT has remained more or less at the same level.
Industry RankSector Rank
OM 16.39%
PM (TTM) 11.4%
GM 28.76%
OM growth 3Y16.51%
OM growth 5Y5.87%
PM growth 3Y14.91%
PM growth 5Y3.22%
GM growth 3Y5.49%
GM growth 5Y1.33%
UFPT Yearly Profit, Operating, Gross MarginsUFPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

6

2. Health

2.1 Basic Checks

UFPT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
UFPT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for UFPT has been increased compared to 5 years ago.
The debt/assets ratio for UFPT is higher compared to a year ago.
UFPT Yearly Shares OutstandingUFPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
UFPT Yearly Total Debt VS Total AssetsUFPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

UFPT has an Altman-Z score of 6.60. This indicates that UFPT is financially healthy and has little risk of bankruptcy at the moment.
UFPT's Altman-Z score of 6.60 is amongst the best of the industry. UFPT outperforms 86.10% of its industry peers.
UFPT has a debt to FCF ratio of 2.26. This is a good value and a sign of high solvency as UFPT would need 2.26 years to pay back of all of its debts.
UFPT has a better Debt to FCF ratio (2.26) than 88.24% of its industry peers.
UFPT has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
UFPT's Debt to Equity ratio of 0.39 is in line compared to the rest of the industry. UFPT outperforms 44.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 2.26
Altman-Z 6.6
ROIC/WACC1.61
WACC8.72%
UFPT Yearly LT Debt VS Equity VS FCFUFPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.77 indicates that UFPT has no problem at all paying its short term obligations.
UFPT's Current ratio of 2.77 is in line compared to the rest of the industry. UFPT outperforms 55.08% of its industry peers.
UFPT has a Quick Ratio of 1.53. This is a normal value and indicates that UFPT is financially healthy and should not expect problems in meeting its short term obligations.
UFPT has a Quick ratio (1.53) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.77
Quick Ratio 1.53
UFPT Yearly Current Assets VS Current LiabilitesUFPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.42% over the past year.
Measured over the past years, UFPT shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.55% on average per year.
The Revenue has grown by 40.98% in the past year. This is a very strong growth!
UFPT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.52% yearly.
EPS 1Y (TTM)34.42%
EPS 3Y53.29%
EPS 5Y23.55%
EPS Q2Q%26.29%
Revenue 1Y (TTM)40.98%
Revenue growth 3Y34.72%
Revenue growth 5Y20.52%
Sales Q2Q%37.21%

3.2 Future

The Earnings Per Share is expected to grow by 14.28% on average over the next years. This is quite good.
The Revenue is expected to grow by 10.43% on average over the next years. This is quite good.
EPS Next Y16.39%
EPS Next 2Y16.01%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue Next Year19.84%
Revenue Next 2Y12.86%
Revenue Next 3Y10.43%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
UFPT Yearly Revenue VS EstimatesUFPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
UFPT Yearly EPS VS EstimatesUFPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 26.16, the valuation of UFPT can be described as expensive.
Based on the Price/Earnings ratio, UFPT is valued a bit cheaper than 77.01% of the companies in the same industry.
When comparing the Price/Earnings ratio of UFPT to the average of the S&P500 Index (27.24), we can say UFPT is valued inline with the index average.
With a Price/Forward Earnings ratio of 22.07, UFPT is valued on the expensive side.
Based on the Price/Forward Earnings ratio, UFPT is valued a bit cheaper than 78.07% of the companies in the same industry.
UFPT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.81.
Industry RankSector Rank
PE 26.16
Fwd PE 22.07
UFPT Price Earnings VS Forward Price EarningsUFPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of UFPT indicates a somewhat cheap valuation: UFPT is cheaper than 78.07% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, UFPT is valued cheaper than 83.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.99
EV/EBITDA 16.5
UFPT Per share dataUFPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

UFPT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of UFPT may justify a higher PE ratio.
UFPT's earnings are expected to grow with 14.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.6
PEG (5Y)1.11
EPS Next 2Y16.01%
EPS Next 3Y14.28%

0

5. Dividend

5.1 Amount

No dividends for UFPT!.
Industry RankSector Rank
Dividend Yield N/A

UFP TECHNOLOGIES INC

NASDAQ:UFPT (8/22/2025, 8:00:02 PM)

After market: 225.74 0 (0%)

225.74

+6.18 (+2.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03
Inst Owners113.87%
Inst Owner Change5.49%
Ins Owners3.69%
Ins Owner Change-3.9%
Market Cap1.74B
Analysts78
Price Target336.09 (48.88%)
Short Float %18.75%
Short Ratio10.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.63%
Min EPS beat(2)2.93%
Max EPS beat(2)8.33%
EPS beat(4)4
Avg EPS beat(4)7.34%
Min EPS beat(4)2.93%
Max EPS beat(4)14.29%
EPS beat(8)7
Avg EPS beat(8)14.58%
EPS beat(12)11
Avg EPS beat(12)27.34%
EPS beat(16)14
Avg EPS beat(16)25.67%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-2.21%
Max Revenue beat(2)3.67%
Revenue beat(4)2
Avg Revenue beat(4)2.15%
Min Revenue beat(4)-2.21%
Max Revenue beat(4)7.43%
Revenue beat(8)5
Avg Revenue beat(8)2.33%
Revenue beat(12)9
Avg Revenue beat(12)3.5%
Revenue beat(16)13
Avg Revenue beat(16)5.26%
PT rev (1m)5.95%
PT rev (3m)-13.52%
EPS NQ rev (1m)-4.3%
EPS NQ rev (3m)-5.06%
EPS NY rev (1m)-0.32%
EPS NY rev (3m)2.07%
Revenue NQ rev (1m)-1.88%
Revenue NQ rev (3m)0.93%
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE 26.16
Fwd PE 22.07
P/S 2.96
P/FCF 23.99
P/OCF 20.88
P/B 4.51
P/tB 34.43
EV/EBITDA 16.5
EPS(TTM)8.63
EY3.82%
EPS(NY)10.23
Fwd EY4.53%
FCF(TTM)9.41
FCFY4.17%
OCF(TTM)10.81
OCFY4.79%
SpS76.34
BVpS50
TBVpS6.56
PEG (NY)1.6
PEG (5Y)1.11
Profitability
Industry RankSector Rank
ROA 10.57%
ROE 17.41%
ROCE 17.06%
ROIC 14%
ROICexc 14.38%
ROICexgc 36.71%
OM 16.39%
PM (TTM) 11.4%
GM 28.76%
FCFM 12.32%
ROA(3y)10.52%
ROA(5y)8.58%
ROE(3y)16.84%
ROE(5y)13.25%
ROIC(3y)11.64%
ROIC(5y)9.67%
ROICexc(3y)11.86%
ROICexc(5y)10.07%
ROICexgc(3y)27.75%
ROICexgc(5y)22.85%
ROCE(3y)14.19%
ROCE(5y)11.78%
ROICexcg growth 3Y28.55%
ROICexcg growth 5Y9.48%
ROICexc growth 3Y27.39%
ROICexc growth 5Y1.08%
OM growth 3Y16.51%
OM growth 5Y5.87%
PM growth 3Y14.91%
PM growth 5Y3.22%
GM growth 3Y5.49%
GM growth 5Y1.33%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 2.26
Debt/EBITDA 1.32
Cap/Depr 60.03%
Cap/Sales 1.84%
Interest Coverage 7.91
Cash Conversion 72.81%
Profit Quality 108.11%
Current Ratio 2.77
Quick Ratio 1.53
Altman-Z 6.6
F-Score4
WACC8.72%
ROIC/WACC1.61
Cap/Depr(3y)91.16%
Cap/Depr(5y)78.11%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.7%
Profit Quality(3y)58.22%
Profit Quality(5y)76.97%
High Growth Momentum
Growth
EPS 1Y (TTM)34.42%
EPS 3Y53.29%
EPS 5Y23.55%
EPS Q2Q%26.29%
EPS Next Y16.39%
EPS Next 2Y16.01%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue 1Y (TTM)40.98%
Revenue growth 3Y34.72%
Revenue growth 5Y20.52%
Sales Q2Q%37.21%
Revenue Next Year19.84%
Revenue Next 2Y12.86%
Revenue Next 3Y10.43%
Revenue Next 5YN/A
EBIT growth 1Y54.09%
EBIT growth 3Y56.96%
EBIT growth 5Y27.59%
EBIT Next Year48.19%
EBIT Next 3Y23.44%
EBIT Next 5YN/A
FCF growth 1Y299.66%
FCF growth 3Y85.71%
FCF growth 5Y17.47%
OCF growth 1Y193.75%
OCF growth 3Y67.03%
OCF growth 5Y16.35%